#begin document (nw/p2.5_c2e/00/p2.5_c2e_0069); part 000
nw/p2.5_c2e/00/p2.5_c2e_0069   0    0                The     DT     (TOP(S(NP(NP*         -    -   -   -   *         *      (ARG1*       (ARG0*           *             *        *   -
nw/p2.5_c2e/00/p2.5_c2e_0069   0    1               drug     NN         (NML(NML*         -    -   -   -   *         *           *            *           *             *        *   -
nw/p2.5_c2e/00/p2.5_c2e_0069   0    2              price     NN                 *)        -    -   -   -   *         *           *            *           *             *        *   -
nw/p2.5_c2e/00/p2.5_c2e_0069   0    3            control     NN                 *)        -    -   -   -   *         *           *            *           *             *        *   -
nw/p2.5_c2e/00/p2.5_c2e_0069   0    4               plan     NN                 *)        -    -   -   -   *         *           *)           *           *             *        *   -
nw/p2.5_c2e/00/p2.5_c2e_0069   0    5               that    WDT       (SBAR(WHNP*)        -    -   -   -   *         *    (R-ARG1*)           *           *             *        *   -
nw/p2.5_c2e/00/p2.5_c2e_0069   0    6              India    NNP            (S(NP*)        -    -   -   -   *    (ARG0*)     (ARG0*)           *           *             *        *   -
nw/p2.5_c2e/00/p2.5_c2e_0069   0    7              plans    VBZ              (VP*       plan  01   1   -   *       (V*)          *            *           *             *        *   -
nw/p2.5_c2e/00/p2.5_c2e_0069   0    8                 to     TO            (S(VP*         -    -   -   -   *    (ARG1*           *            *           *             *        *   -
nw/p2.5_c2e/00/p2.5_c2e_0069   0    9              adopt     VB        (VP*)))))))     adopt  01   1   -   *         *)        (V*)           *)          *             *        *   -
nw/p2.5_c2e/00/p2.5_c2e_0069   0   10                has    VBZ              (VP*         -    -   -   -   *         *           *            *           *             *        *   -
nw/p2.5_c2e/00/p2.5_c2e_0069   0   11             caused    VBN              (VP*      cause  01   -   -   *         *           *          (V*)          *             *        *   -
nw/p2.5_c2e/00/p2.5_c2e_0069   0   12    dissatisfaction     NN              (NP*)        -    -   -   -   *         *           *       (ARG1*)          *             *        *   -
nw/p2.5_c2e/00/p2.5_c2e_0069   0   13              among     IN              (PP*         -    -   -   -   *         *           *   (ARGM-LOC*           *             *        *   -
nw/p2.5_c2e/00/p2.5_c2e_0069   0   14             Indian     JJ           (NP(NP*         -    -   -   -   *         *           *            *      (ARG0*             *        *   -
nw/p2.5_c2e/00/p2.5_c2e_0069   0   15               drug     NN                 *         -    -   -   -   *         *           *            *           *             *        *   -
nw/p2.5_c2e/00/p2.5_c2e_0069   0   16             makers    NNS                 *)        -    -   -   -   *         *           *            *           *)            *        *   -
nw/p2.5_c2e/00/p2.5_c2e_0069   0   17                  ,      ,                 *         -    -   -   -   *         *           *            *           *             *        *   -
nw/p2.5_c2e/00/p2.5_c2e_0069   0   18                who     WP       (SBAR(WHNP*)        -    -   -   -   *         *           *            *    (R-ARG0*)            *        *   -
nw/p2.5_c2e/00/p2.5_c2e_0069   0   19            believe    VBP            (S(VP*    believe  01   1   -   *         *           *            *         (V*)            *        *   -
nw/p2.5_c2e/00/p2.5_c2e_0069   0   20               this     DT       (SBAR(S(NP*)        -    -   -   -   *         *           *            *      (ARG1*        (ARG0*)       *   -
nw/p2.5_c2e/00/p2.5_c2e_0069   0   21               will     MD              (VP*         -    -   -   -   *         *           *            *           *    (ARGM-MOD*)       *   -
nw/p2.5_c2e/00/p2.5_c2e_0069   0   22                not     RB        (VP(CONJP*         -    -   -   -   *         *           *            *           *             *        *   -
nw/p2.5_c2e/00/p2.5_c2e_0069   0   23               only     RB                 *)        -    -   -   -   *         *           *            *           *             *        *   -
nw/p2.5_c2e/00/p2.5_c2e_0069   0   24               slow     VB              (VP*       slow  03   2   -   *         *           *            *           *           (V*)       *   -
nw/p2.5_c2e/00/p2.5_c2e_0069   0   25               down     RP             (PRT*)        -    -   -   -   *         *           *            *           *             *        *   -
nw/p2.5_c2e/00/p2.5_c2e_0069   0   26     pharmaceutical     JJ              (NP*         -    -   -   -   *         *           *            *           *        (ARG1*        *   -
nw/p2.5_c2e/00/p2.5_c2e_0069   0   27            exports    NNS                *))        -    -   -   -   *         *           *            *           *             *)       *   -
nw/p2.5_c2e/00/p2.5_c2e_0069   0   28                but     CC           (CONJP*         -    -   -   -   *         *           *            *           *             *        *   -
nw/p2.5_c2e/00/p2.5_c2e_0069   0   29               also     RB                 *)        -    -   -   -   *         *           *            *           *             *        *   -
nw/p2.5_c2e/00/p2.5_c2e_0069   0   30               make     VB              (VP*       make   -   4   -   *         *           *            *           *             *        *   -
nw/p2.5_c2e/00/p2.5_c2e_0069   0   31               many     JJ         (S(NP(NP*         -    -   -   -   *         *           *            *           *             *   (ARG0*   -
nw/p2.5_c2e/00/p2.5_c2e_0069   0   32            workers    NNS                 *)        -    -   -   -   *         *           *            *           *             *        *   -
nw/p2.5_c2e/00/p2.5_c2e_0069   0   33                 in     IN              (PP*         -    -   -   -   *         *           *            *           *             *        *   -
nw/p2.5_c2e/00/p2.5_c2e_0069   0   34                the     DT              (NP*         -    -   -   -   *         *           *            *           *             *        *   -
nw/p2.5_c2e/00/p2.5_c2e_0069   0   35           industry     NN               *)))        -    -   -   -   *         *           *            *           *             *        *)  -
nw/p2.5_c2e/00/p2.5_c2e_0069   0   36               lose     VB              (VP*       lose  02   4   -   *         *           *            *           *             *      (V*)  -
nw/p2.5_c2e/00/p2.5_c2e_0069   0   37              their   PRP$              (NP*         -    -   -   -   *         *           *            *           *             *   (ARG1*   -
nw/p2.5_c2e/00/p2.5_c2e_0069   0   38               jobs    NNS   *)))))))))))))))        -    -   -   -   *         *           *            *)          *)            *        *)  -
nw/p2.5_c2e/00/p2.5_c2e_0069   0   39                  .      .                *))        -    -   -   -   *         *           *            *           *             *        *   -

nw/p2.5_c2e/00/p2.5_c2e_0069   0    0       Reports   NNS    (TOP(S(NP*)          -    -   -   -   *    (ARG0*)       *        *   -
nw/p2.5_c2e/00/p2.5_c2e_0069   0    1          said   VBD          (VP*          say  01   4   -   *       (V*)       *        *   -
nw/p2.5_c2e/00/p2.5_c2e_0069   0    2          that    IN        (SBAR*           -    -   -   -   *    (ARG1*        *        *   -
nw/p2.5_c2e/00/p2.5_c2e_0069   0    3        Indian    JJ  (S(NP(NP(NP*           -    -   -   -   *         *   (ARG0*   (ARG0*   -
nw/p2.5_c2e/00/p2.5_c2e_0069   0    4      Minister   NNP             *)          -    -   -   -   *         *        *        *   -
nw/p2.5_c2e/00/p2.5_c2e_0069   0    5           for    IN          (PP*           -    -   -   -   *         *        *        *   -
nw/p2.5_c2e/00/p2.5_c2e_0069   0    6     Chemicals   NNS          (NP*           -    -   -   -   *         *        *        *   -
nw/p2.5_c2e/00/p2.5_c2e_0069   0    7             ,     ,             *           -    -   -   -   *         *        *        *   -
nw/p2.5_c2e/00/p2.5_c2e_0069   0    8    Fertilizer   NNP             *           -    -   -   -   *         *        *        *   -
nw/p2.5_c2e/00/p2.5_c2e_0069   0    9           and    CC             *           -    -   -   -   *         *        *        *   -
nw/p2.5_c2e/00/p2.5_c2e_0069   0   10         Steel   NNP           *)))          -    -   -   -   *         *        *        *   -
nw/p2.5_c2e/00/p2.5_c2e_0069   0   11             ,     ,             *           -    -   -   -   *         *        *        *   -
nw/p2.5_c2e/00/p2.5_c2e_0069   0   12           Ram   NNP          (NP*           -    -   -   -   *         *        *        *   -
nw/p2.5_c2e/00/p2.5_c2e_0069   0   13         Vilas   NNP             *           -    -   -   -   *         *        *        *   -
nw/p2.5_c2e/00/p2.5_c2e_0069   0   14        Paswan   NNP            *))          -    -   -   -   *         *        *)       *)  -
nw/p2.5_c2e/00/p2.5_c2e_0069   0   15         hopes   VBZ          (VP*         hope  01   -   -   *         *      (V*)       *   -
nw/p2.5_c2e/00/p2.5_c2e_0069   0   16            to    TO        (S(VP*           -    -   -   -   *         *   (ARG1*        *   -
nw/p2.5_c2e/00/p2.5_c2e_0069   0   17     implement    VB          (VP*    implement  01   -   -   *         *        *      (V*)  -
nw/p2.5_c2e/00/p2.5_c2e_0069   0   18         price    NN       (NP(NP*           -    -   -   -   *         *        *   (ARG1*   -
nw/p2.5_c2e/00/p2.5_c2e_0069   0   19       control    NN             *)          -    -   -   -   *         *        *        *   -
nw/p2.5_c2e/00/p2.5_c2e_0069   0   20            on    IN          (PP*           -    -   -   -   *         *        *        *   -
nw/p2.5_c2e/00/p2.5_c2e_0069   0   21          more   JJR          (NP*           -    -   -   -   *         *        *        *   -
nw/p2.5_c2e/00/p2.5_c2e_0069   0   22         drugs   NNS    *))))))))))          -    -   -   -   *         *)       *)       *)  -
nw/p2.5_c2e/00/p2.5_c2e_0069   0   23             .     .            *))          -    -   -   -   *         *        *        *   -

nw/p2.5_c2e/00/p2.5_c2e_0069   0    0          Paswan     NNP   (TOP(S(NP*)          -    -   -   -   *    (ARG0*)       *            *        (ARG0*)            *   -
nw/p2.5_c2e/00/p2.5_c2e_0069   0    1           hopes     VBZ         (VP*         hope  01   -   -   *       (V*)       *            *             *             *   -
nw/p2.5_c2e/00/p2.5_c2e_0069   0    2              to      TO       (S(VP*           -    -   -   -   *    (ARG1*        *            *             *             *   -
nw/p2.5_c2e/00/p2.5_c2e_0069   0    3            make      VB      (VP(VP*         make   -   1   -   *         *        *            *             *             *   -
nw/p2.5_c2e/00/p2.5_c2e_0069   0    4               a      DT      (NP(NP*           -    -   -   -   *         *        *            *             *             *   -
nw/p2.5_c2e/00/p2.5_c2e_0069   0    5             one      CD        (NML*           -    -   -   -   *         *        *            *             *             *   -
nw/p2.5_c2e/00/p2.5_c2e_0069   0    6              -     HYPH            *           -    -   -   -   *         *        *            *             *             *   -
nw/p2.5_c2e/00/p2.5_c2e_0069   0    7            time      NN            *)          -    -   -   -   *         *        *            *             *             *   -
nw/p2.5_c2e/00/p2.5_c2e_0069   0    8           price      NN            *           -    -   -   -   *         *        *            *             *             *   -
nw/p2.5_c2e/00/p2.5_c2e_0069   0    9       reduction      NN            *)          -    -   -   -   *         *        *            *             *             *   -
nw/p2.5_c2e/00/p2.5_c2e_0069   0   10              on      IN         (PP*           -    -   -   -   *         *        *            *             *             *   -
nw/p2.5_c2e/00/p2.5_c2e_0069   0   11             the      DT      (NP(NP*           -    -   -   -   *         *   (ARG1*       (ARG2*             *             *   -
nw/p2.5_c2e/00/p2.5_c2e_0069   0   12            354       CD            *           -    -   -   -   *         *        *            *             *             *   -
nw/p2.5_c2e/00/p2.5_c2e_0069   0   13       essential      JJ            *           -    -   -   -   *         *        *            *             *             *   -
nw/p2.5_c2e/00/p2.5_c2e_0069   0   14           drugs     NNS            *)          -    -   -   -   *         *        *)           *)            *             *   -
nw/p2.5_c2e/00/p2.5_c2e_0069   0   15      designated     VBN         (VP*    designate  01   2   -   *         *      (V*)           *             *             *   -
nw/p2.5_c2e/00/p2.5_c2e_0069   0   16              by      IN         (PP*           -    -   -   -   *         *   (ARG0*            *             *             *   -
nw/p2.5_c2e/00/p2.5_c2e_0069   0   17             the      DT         (NP*           -    -   -   -   *         *        *            *             *             *   -
nw/p2.5_c2e/00/p2.5_c2e_0069   0   18             WHO     NNP          *)))          -    -   -   -   *         *        *)           *             *             *   -
nw/p2.5_c2e/00/p2.5_c2e_0069   0   19          -LRB-   -LRB-             *           -    -   -   -   *         *        *            *             *             *   -
nw/p2.5_c2e/00/p2.5_c2e_0069   0   20       including     VBG         (VP*      include  01   -   -   *         *        *          (V*)            *             *   -
nw/p2.5_c2e/00/p2.5_c2e_0069   0   21              in      IN         (PP*           -    -   -   -   *         *        *   (ARGM-LOC*             *             *   -
nw/p2.5_c2e/00/p2.5_c2e_0069   0   22            them     PRP        (NP*))          -    -   -   -   *         *        *            *)            *             *   -
nw/p2.5_c2e/00/p2.5_c2e_0069   0   23            some      DT         (NP*           -    -   -   -   *         *        *       (ARG1*             *             *   -
nw/p2.5_c2e/00/p2.5_c2e_0069   0   24    hypertension      NN    (NML(NML*           -    -   -   -   *         *        *            *             *             *   -
nw/p2.5_c2e/00/p2.5_c2e_0069   0   25           drugs     NNS            *)          -    -   -   -   *         *        *            *             *             *   -
nw/p2.5_c2e/00/p2.5_c2e_0069   0   26             and      CC            *           -    -   -   -   *         *        *            *             *             *   -
nw/p2.5_c2e/00/p2.5_c2e_0069   0   27     antibiotics     NNS     (NML*))))          -    -   -   -   *         *        *            *)            *             *   -
nw/p2.5_c2e/00/p2.5_c2e_0069   0   28          -RRB-   -RRB-           *)))          -    -   -   -   *         *        *            *             *             *   -
nw/p2.5_c2e/00/p2.5_c2e_0069   0   29           first      RB       (ADVP*)          -    -   -   -   *         *        *            *             *             *   -
nw/p2.5_c2e/00/p2.5_c2e_0069   0   30         through      RP         (PP*           -    -   -   -   *         *        *            *             *             *   -
nw/p2.5_c2e/00/p2.5_c2e_0069   0   31    negotiations     NNS       (NP*)))          -    -   -   -   *         *        *            *             *             *   -
nw/p2.5_c2e/00/p2.5_c2e_0069   0   32             and      CC            *           -    -   -   -   *         *        *            *             *             *   -
nw/p2.5_c2e/00/p2.5_c2e_0069   0   33            then      RB       (ADVP*)          -    -   -   -   *         *        *            *    (ARGM-TMP*)            *   -
nw/p2.5_c2e/00/p2.5_c2e_0069   0   34         connect      VB         (VP*      connect  01   2   -   *         *        *            *           (V*)            *   -
nw/p2.5_c2e/00/p2.5_c2e_0069   0   35          future      JJ      (NP(NP*           -    -   -   -   *         *        *            *        (ARG1*    (ARGM-TMP*)  -
nw/p2.5_c2e/00/p2.5_c2e_0069   0   36        increase      NN            *)    increase  01   1   -   *         *        *            *             *           (V*)  -
nw/p2.5_c2e/00/p2.5_c2e_0069   0   37              of      IN         (PP*           -    -   -   -   *         *        *            *             *        (ARG1*   -
nw/p2.5_c2e/00/p2.5_c2e_0069   0   38            drug      NN         (NP*           -    -   -   -   *         *        *            *             *             *   -
nw/p2.5_c2e/00/p2.5_c2e_0069   0   39          prices     NNS          *)))          -    -   -   -   *         *        *            *             *)            *)  -
nw/p2.5_c2e/00/p2.5_c2e_0069   0   40            with      IN         (PP*           -    -   -   -   *         *        *            *        (ARG2*             *   -
nw/p2.5_c2e/00/p2.5_c2e_0069   0   41       inflation      NN   (NP*)))))))          -    -   -   -   *         *)       *            *             *)            *   -
nw/p2.5_c2e/00/p2.5_c2e_0069   0   42               .       .           *))          -    -   -   -   *         *        *            *             *             *   -

nw/p2.5_c2e/00/p2.5_c2e_0069   0    0     Currently     RB            (TOP(S(ADVP*)         -    -   -   -   *         *             *        *   -
nw/p2.5_c2e/00/p2.5_c2e_0069   0    1         India    NNP                    (NP*)         -    -   -   -   *         *             *        *   -
nw/p2.5_c2e/00/p2.5_c2e_0069   0    2           has    VBZ                    (VP*        have   -   1   -   *         *             *        *   -
nw/p2.5_c2e/00/p2.5_c2e_0069   0    3             a     DT                 (NP(NP*          -    -   -   -   *         *             *        *   -
nw/p2.5_c2e/00/p2.5_c2e_0069   0    4         total     NN                       *)         -    -   -   -   *         *             *        *   -
nw/p2.5_c2e/00/p2.5_c2e_0069   0    5            of     IN                    (PP*          -    -   -   -   *         *             *        *   -
nw/p2.5_c2e/00/p2.5_c2e_0069   0    6           74      CD                 (NP(NP*          -    -   -   -   *         *        (ARG1*        *   -
nw/p2.5_c2e/00/p2.5_c2e_0069   0    7         price     NN                  (ADJP*          -    -   -   -   *    (ARG1*)            *        *   -
nw/p2.5_c2e/00/p2.5_c2e_0069   0    8            -    HYPH                       *          -    -   -   -   *         *             *        *   -
nw/p2.5_c2e/00/p2.5_c2e_0069   0    9    controlled    VBN                       *)    control  01   -   -   *       (V*)            *        *   -
nw/p2.5_c2e/00/p2.5_c2e_0069   0   10         drugs    NNS                       *)         -    -   -   -   *         *             *)       *   -
nw/p2.5_c2e/00/p2.5_c2e_0069   0   11             ,      ,                       *          -    -   -   -   *         *             *        *   -
nw/p2.5_c2e/00/p2.5_c2e_0069   0   12         which    WDT             (SBAR(WHNP*)         -    -   -   -   *         *      (R-ARG1*)       *   -
nw/p2.5_c2e/00/p2.5_c2e_0069   0   13          will     MD                  (S(VP*          -    -   -   -   *         *    (ARGM-MOD*)       *   -
nw/p2.5_c2e/00/p2.5_c2e_0069   0   14            be     VB                    (VP*          -    -   -   -   *         *             *        *   -
nw/p2.5_c2e/00/p2.5_c2e_0069   0   15     increased    VBN                    (VP*    increase  01   -   -   *         *           (V*)       *   -
nw/p2.5_c2e/00/p2.5_c2e_0069   0   16            to     IN                    (PP*          -    -   -   -   *         *        (ARG4*        *   -
nw/p2.5_c2e/00/p2.5_c2e_0069   0   17            an     DT                 (NP(NP*          -    -   -   -   *         *             *        *   -
nw/p2.5_c2e/00/p2.5_c2e_0069   0   18        amount     NN                       *)         -    -   -   -   *         *             *        *   -
nw/p2.5_c2e/00/p2.5_c2e_0069   0   19            of     IN                    (PP*          -    -   -   -   *         *             *        *   -
nw/p2.5_c2e/00/p2.5_c2e_0069   0   20          more    JJR              (NP(NP(QP*          -    -   -   -   *         *             *        *   -
nw/p2.5_c2e/00/p2.5_c2e_0069   0   21          than     IN                       *          -    -   -   -   *         *             *        *   -
nw/p2.5_c2e/00/p2.5_c2e_0069   0   22           40      CD                       *          -    -   -   -   *         *             *        *   -
nw/p2.5_c2e/00/p2.5_c2e_0069   0   23             %     NN                      *))         -    -   -   -   *         *             *        *   -
nw/p2.5_c2e/00/p2.5_c2e_0069   0   24            of     IN                    (PP*          -    -   -   -   *         *             *        *   -
nw/p2.5_c2e/00/p2.5_c2e_0069   0   25           the     DT                 (NP(NP*          -    -   -   -   *         *             *   (ARG1*   -
nw/p2.5_c2e/00/p2.5_c2e_0069   0   26         drugs    NNS                       *)         -    -   -   -   *         *             *        *)  -
nw/p2.5_c2e/00/p2.5_c2e_0069   0   27          sold    VBN                    (VP*        sell  01   1   -   *         *             *      (V*)  -
nw/p2.5_c2e/00/p2.5_c2e_0069   0   28            by     IN                    (PP*          -    -   -   -   *         *             *   (ARG0*   -
nw/p2.5_c2e/00/p2.5_c2e_0069   0   29         India    NNP   (NP*))))))))))))))))))         -    -   -   -   *         *             *)       *)  -
nw/p2.5_c2e/00/p2.5_c2e_0069   0   30             .      .                      *))         -    -   -   -   *         *             *        *   -

nw/p2.5_c2e/00/p2.5_c2e_0069   0    0          FICCI    NNP      (TOP(S(NP(NML*            -    -   -   -   *   (ARG0*        *             *        *   -
nw/p2.5_c2e/00/p2.5_c2e_0069   0    1           Vice    NNP                   *            -    -   -   -   *        *        *             *        *   -
nw/p2.5_c2e/00/p2.5_c2e_0069   0    2      President    NNP                   *)           -    -   -   -   *        *        *             *        *   -
nw/p2.5_c2e/00/p2.5_c2e_0069   0    3          Habil    NNP                   *            -    -   -   -   *        *        *             *        *   -
nw/p2.5_c2e/00/p2.5_c2e_0069   0    4    Khorakiwala    NNP                   *)           -    -   -   -   *        *)       *             *        *   -
nw/p2.5_c2e/00/p2.5_c2e_0069   0    5           said    VBD                (VP*           say  01   1   -   *      (V*)       *             *        *   -
nw/p2.5_c2e/00/p2.5_c2e_0069   0    6           that     IN              (SBAR*            -    -   -   -   *   (ARG1*        *             *        *   -
nw/p2.5_c2e/00/p2.5_c2e_0069   0    7             if     IN            (S(SBAR*            -    -   -   -   *        *        *    (ARGM-ADV*        *   -
nw/p2.5_c2e/00/p2.5_c2e_0069   0    8          price     NN          (S(NP(NML*            -    -   -   -   *        *   (ARG1*             *        *   -
nw/p2.5_c2e/00/p2.5_c2e_0069   0    9             -    HYPH                   *            -    -   -   -   *        *        *             *        *   -
nw/p2.5_c2e/00/p2.5_c2e_0069   0   10        control     NN                   *)           -    -   -   -   *        *        *             *        *   -
nw/p2.5_c2e/00/p2.5_c2e_0069   0   11       measures    NNS                   *)           -    -   -   -   *        *        *)            *        *   -
nw/p2.5_c2e/00/p2.5_c2e_0069   0   12            are    VBP                (VP*            -    -   -   -   *        *        *             *        *   -
nw/p2.5_c2e/00/p2.5_c2e_0069   0   13    promulgated    VBN             (VP*))))   promulgate  01   -   -   *        *      (V*)            *)       *   -
nw/p2.5_c2e/00/p2.5_c2e_0069   0   14              ,      ,                   *            -    -   -   -   *        *        *             *        *   -
nw/p2.5_c2e/00/p2.5_c2e_0069   0   15           even     RB                (NP*            -    -   -   -   *        *        *        (ARG0*        *   -
nw/p2.5_c2e/00/p2.5_c2e_0069   0   16          large     JJ                   *            -    -   -   -   *        *        *             *        *   -
nw/p2.5_c2e/00/p2.5_c2e_0069   0   17           drug     NN                   *            -    -   -   -   *        *        *             *        *   -
nw/p2.5_c2e/00/p2.5_c2e_0069   0   18         makers    NNS                   *)           -    -   -   -   *        *        *             *)       *   -
nw/p2.5_c2e/00/p2.5_c2e_0069   0   19           will     MD                (VP*            -    -   -   -   *        *        *    (ARGM-MOD*)       *   -
nw/p2.5_c2e/00/p2.5_c2e_0069   0   20           find     VB                (VP*          find  02   3   -   *        *        *           (V*)       *   -
nw/p2.5_c2e/00/p2.5_c2e_0069   0   21             it    PRP          (S(NP(NP*))           -    -   -   -   *        *        *        (ARG1*        *   -
nw/p2.5_c2e/00/p2.5_c2e_0069   0   22           hard     JJ              (ADJP*)           -    -   -   -   *        *        *             *        *   -
nw/p2.5_c2e/00/p2.5_c2e_0069   0   23             to     TO              (S(VP*            -    -   -   -   *        *        *             *        *   -
nw/p2.5_c2e/00/p2.5_c2e_0069   0   24       maintain     VB                (VP*      maintain  01   1   -   *        *        *             *      (V*)  -
nw/p2.5_c2e/00/p2.5_c2e_0069   0   25          their   PRP$             (NP(NP*            -    -   -   -   *        *        *             *   (ARG1*   -
nw/p2.5_c2e/00/p2.5_c2e_0069   0   26         budget     NN                   *)           -    -   -   -   *        *        *             *        *   -
nw/p2.5_c2e/00/p2.5_c2e_0069   0   27            for     IN                (PP*            -    -   -   -   *        *        *             *        *   -
nw/p2.5_c2e/00/p2.5_c2e_0069   0   28       research     NN             (NP(NP*      research   -   1   -   *        *        *             *        *   -
nw/p2.5_c2e/00/p2.5_c2e_0069   0   29            and     CC                   *            -    -   -   -   *        *        *             *        *   -
nw/p2.5_c2e/00/p2.5_c2e_0069   0   30    development     NN                   *)           -    -   -   -   *        *        *             *        *   -
nw/p2.5_c2e/00/p2.5_c2e_0069   0   31             of     IN                (PP*            -    -   -   -   *        *        *             *        *   -
nw/p2.5_c2e/00/p2.5_c2e_0069   0   32          drugs    NNS   (NP*))))))))))))))           -    -   -   -   *        *)       *             *)       *)  -
nw/p2.5_c2e/00/p2.5_c2e_0069   0   33              .      .                  *))           -    -   -   -   *        *        *             *        *   -

nw/p2.5_c2e/00/p2.5_c2e_0069   0    0            Ajay   NNP  (TOP(S(NP(NP*        -    -   -   -   *   (ARG0*             *        *             *   -
nw/p2.5_c2e/00/p2.5_c2e_0069   0    1         Piramal   NNP              *)       -    -   -   -   *        *             *        *             *   -
nw/p2.5_c2e/00/p2.5_c2e_0069   0    2               ,     ,              *        -    -   -   -   *        *             *        *             *   -
nw/p2.5_c2e/00/p2.5_c2e_0069   0    3        chairman    NN        (NP(NP*)       -    -   -   -   *        *             *        *             *   -
nw/p2.5_c2e/00/p2.5_c2e_0069   0    4              of    IN           (PP*        -    -   -   -   *        *             *        *             *   -
nw/p2.5_c2e/00/p2.5_c2e_0069   0    5            drug    NN       (NP(NML*        -    -   -   -   *        *             *        *             *   -
nw/p2.5_c2e/00/p2.5_c2e_0069   0    6           maker    NN              *)       -    -   -   -   *        *             *        *             *   -
nw/p2.5_c2e/00/p2.5_c2e_0069   0    7        Nicholas   NNP              *        -    -   -   -   *        *             *        *             *   -
nw/p2.5_c2e/00/p2.5_c2e_0069   0    8         Piramal   NNP           *))))       -    -   -   -   *        *)            *        *             *   -
nw/p2.5_c2e/00/p2.5_c2e_0069   0    9               ,     ,              *        -    -   -   -   *        *             *        *             *   -
nw/p2.5_c2e/00/p2.5_c2e_0069   0   10            said   VBD           (VP*       say  01   1   -   *      (V*)            *        *             *   -
nw/p2.5_c2e/00/p2.5_c2e_0069   0   11               ,     ,              *        -    -   -   -   *        *             *        *             *   -
nw/p2.5_c2e/00/p2.5_c2e_0069   0   12               "    ``              *        -    -   -   -   *        *             *        *             *   -
nw/p2.5_c2e/00/p2.5_c2e_0069   0   13             The    DT    (S(S(NP(NP*        -    -   -   -   *   (ARG1*             *   (ARG1*             *   -
nw/p2.5_c2e/00/p2.5_c2e_0069   0   14    continuously    RB         (ADJP*        -    -   -   -   *        *    (ARGM-MNR*)       *             *   -
nw/p2.5_c2e/00/p2.5_c2e_0069   0   15         falling   VBG              *)     fall  01   -   -   *        *           (V*)       *             *   -
nw/p2.5_c2e/00/p2.5_c2e_0069   0   16          prices   NNS              *)       -    -   -   -   *        *        (ARG1*)       *             *   -
nw/p2.5_c2e/00/p2.5_c2e_0069   0   17              of    IN           (PP*        -    -   -   -   *        *             *        *             *   -
nw/p2.5_c2e/00/p2.5_c2e_0069   0   18          common    JJ           (NP*        -    -   -   -   *        *             *        *             *   -
nw/p2.5_c2e/00/p2.5_c2e_0069   0   19          export    NN              *        -    -   -   -   *        *             *        *             *   -
nw/p2.5_c2e/00/p2.5_c2e_0069   0   20           drugs   NNS            *)))       -    -   -   -   *        *             *        *)            *   -
nw/p2.5_c2e/00/p2.5_c2e_0069   0   21            have   VBP           (VP*        -    -   -   -   *        *             *        *             *   -
nw/p2.5_c2e/00/p2.5_c2e_0069   0   22        resulted   VBN           (VP*    result  01   -   -   *        *             *      (V*)            *   -
nw/p2.5_c2e/00/p2.5_c2e_0069   0   23              in    IN           (PP*        -    -   -   -   *        *             *   (ARG2*             *   -
nw/p2.5_c2e/00/p2.5_c2e_0069   0   24            thin    JJ           (NP*        -    -   -   -   *        *             *        *             *   -
nw/p2.5_c2e/00/p2.5_c2e_0069   0   25         profits   NNS          *)))))       -    -   -   -   *        *             *        *)            *   -
nw/p2.5_c2e/00/p2.5_c2e_0069   0   26               ,     ,              *        -    -   -   -   *        *             *        *             *   -
nw/p2.5_c2e/00/p2.5_c2e_0069   0   27              so    CC              *        -    -   -   -   *        *             *        *             *   -
nw/p2.5_c2e/00/p2.5_c2e_0069   0   28            they   PRP         (S(NP*)       -    -   -   -   *        *             *        *        (ARG0*)  -
nw/p2.5_c2e/00/p2.5_c2e_0069   0   29              ca    MD           (VP*        -    -   -   -   *        *             *        *    (ARGM-MOD*)  -
nw/p2.5_c2e/00/p2.5_c2e_0069   0   30             n't    RB              *        -    -   -   -   *        *             *        *    (ARGM-NEG*)  -
nw/p2.5_c2e/00/p2.5_c2e_0069   0   31          impose    VB           (VP*    impose  01   1   -   *        *             *        *           (V*)  -
nw/p2.5_c2e/00/p2.5_c2e_0069   0   32          limits   NNS        (NP(NP*)       -    -   -   -   *        *             *        *        (ARG1*)  -
nw/p2.5_c2e/00/p2.5_c2e_0069   0   33              on    IN           (PP*        -    -   -   -   *        *             *        *        (ARG2*   -
nw/p2.5_c2e/00/p2.5_c2e_0069   0   34         profits   NNS         (NP*)))       -    -   -   -   *        *             *        *             *)  -
nw/p2.5_c2e/00/p2.5_c2e_0069   0   35             any    RB         (ADVP*        -    -   -   -   *        *             *        *    (ARGM-TMP*   -
nw/p2.5_c2e/00/p2.5_c2e_0069   0   36            more   RBR         *))))))       -    -   -   -   *        *)            *        *             *)  -
nw/p2.5_c2e/00/p2.5_c2e_0069   0   37               .     .             *))       -    -   -   -   *        *             *        *             *   -

nw/p2.5_c2e/00/p2.5_c2e_0069   0    0             On    IN          (TOP(S(PP*           -    -   -   -   *    (ARGM-DIS*             *         *   -
nw/p2.5_c2e/00/p2.5_c2e_0069   0    1            the    DT                (NP*           -    -   -   -   *             *             *         *   -
nw/p2.5_c2e/00/p2.5_c2e_0069   0    2       contrary    NN                  *))          -    -   -   -   *             *)            *         *   -
nw/p2.5_c2e/00/p2.5_c2e_0069   0    3              ,     ,                   *           -    -   -   -   *             *             *         *   -
nw/p2.5_c2e/00/p2.5_c2e_0069   0    4            the    DT                (NP*           -    -   -   -   *        (ARG0*             *         *   -
nw/p2.5_c2e/00/p2.5_c2e_0069   0    5     government    NN                   *)          -    -   -   -   *             *)            *         *   -
nw/p2.5_c2e/00/p2.5_c2e_0069   0    6         should    MD                (VP*           -    -   -   -   *    (ARGM-MOD*)            *         *   -
nw/p2.5_c2e/00/p2.5_c2e_0069   0    7       consider    VB                (VP*     consider  02   2   -   *           (V*)            *         *   -
nw/p2.5_c2e/00/p2.5_c2e_0069   0    8            how   WRB       (SBAR(WHADVP*)          -    -   -   -   *        (ARG1*    (ARGM-MNR*)        *   -
nw/p2.5_c2e/00/p2.5_c2e_0069   0    9             to    TO              (S(VP*           -    -   -   -   *             *             *         *   -
nw/p2.5_c2e/00/p2.5_c2e_0069   0   10      encourage    VB                (VP*    encourage  01   2   -   *             *           (V*)        *   -
nw/p2.5_c2e/00/p2.5_c2e_0069   0   11             us   PRP                (NP*)          -    -   -   -   *             *        (ARG1*)   (ARG0*)  -
nw/p2.5_c2e/00/p2.5_c2e_0069   0   12             to    TO              (S(VP*           -    -   -   -   *             *        (ARG2*         *   -
nw/p2.5_c2e/00/p2.5_c2e_0069   0   13       increase    VB                (VP*     increase  01   -   -   *             *             *       (V*)  -
nw/p2.5_c2e/00/p2.5_c2e_0069   0   14     investment    NN             (NP(NP*)          -    -   -   -   *             *             *    (ARG1*   -
nw/p2.5_c2e/00/p2.5_c2e_0069   0   15             in    IN                (PP*           -    -   -   -   *             *             *         *   -
nw/p2.5_c2e/00/p2.5_c2e_0069   0   16       research    NN             (NP(NP*     research   -   1   -   *             *             *         *   -
nw/p2.5_c2e/00/p2.5_c2e_0069   0   17            and    CC                   *           -    -   -   -   *             *             *         *   -
nw/p2.5_c2e/00/p2.5_c2e_0069   0   18    development    NN                   *)          -    -   -   -   *             *             *         *   -
nw/p2.5_c2e/00/p2.5_c2e_0069   0   19             of    IN                (PP*           -    -   -   -   *             *             *         *   -
nw/p2.5_c2e/00/p2.5_c2e_0069   0   20          drugs   NNS   (NP*))))))))))))))          -    -   -   -   *             *)            *)        *)  -
nw/p2.5_c2e/00/p2.5_c2e_0069   0   21              .     .                   *           -    -   -   -   *             *             *         *   -
nw/p2.5_c2e/00/p2.5_c2e_0069   0   22              "    ''                  *))          -    -   -   -   *             *             *         *   -

#end document
